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Abstract
Inappropriate trypsinogen activation is discussed as an early intracellular event in the secretagogue-induced model of
acute pancreatitis. However, the mechanisms by which trypsinogen is activated are not well characterized. In the present
 . w .work, trypsinogen activation was studied in intact acinar cells using bis- CBZ-arginyl -Rhodamine 110 CBZ-Arg -Rho2
x110 as a cell-permeant substrate for trypsin and also independently via the formation of trypsinogen activation peptide
 .TAP . Preincubation with 10 nM caerulein increased the Rho 110-substrate cleavage more than threefold. This proteolytic
 .activity was fully sensitive to a benzamidine BA -type serine protease inhibitor. The appearance of enzymatic activity was
paralleled by the formation of TAP. The lack of effect of the high-molecular soybean trypsin inhibitor indicates an
intracellular substrate cleavage. The cathepsin B inhibitor CA-074 prevented neither the caerulein-induced formation of
 .TAP nor the CBZ-Arg -Rho 110-cleaving activity. BA inhibited the Rho 110-substrate cleavage and significantly reduced2
the TAP formation. These results show that trypsinogen activation in caerulein-hyperstimulated acinar cells may occur
independently of the activity of cathepsin B. On the contrary, the effect of BA suggests the role of a serine protease in
trypsinogen activation. q 1997 Elsevier Science B.V.
 .Keywords: Rhodamine 110-based substrate; Cathepsin B inhibitor; Benzamidine; Trypsin ogen ; Pancreatic acinar cell
1. Introduction
The premature activation of digestive enzymes
within the pancreatic gland is discussed as an impor-
tant event which contributes to the pathological alter-
w xations leading to acute pancreatitis 1–3 . Although
Abbreviations: Rho 110, rhodamine 110; BA, benzamidine;
TAP, trypsinogen activation peptide; SBTI, soybean trypsin in-
hibitor
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the pathogenesis of this disease is not fully under-
stood, there are many hints that the early alterations
of the inflamed pancreas occur within the acinar
cells.
Supramaximal stimulation by the cholecystokinin
 .CCK analogue caerulein induces a mild edematous
w xpancreatitis in rats 4,5 . Very early in the time course
of this experimental model, an enhanced trypsin ac-
tivity could be measured in pancreas homogenates
w x1,3,6,7 which is accompanied by increased levels of
 . w xtrypsinogen activation peptide TAP 7 .
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However, the mechanisms leading to cell injury
can be studied only in a limited manner by biochemi-
cal analyses of total homogenates or fractions of
pancreatic tissue. Hormonal hyperstimulation of aci-
nar cells in vitro is a useful experimental tool to get
insight into the intracellular mechanisms of prema-
w xture zymogen activation. Leach et al. 8 demon-
strated the action of a serine protease in isolated
pancreatic acini stimulated by high dosages of CCK
by measuring the conversion of procarboxypeptidase
A1 into carboxypeptidase A1. Although an action by
trypsin was discussed by these authors as being the
underlying phenomenon of this zymogen activation,
the trypsin activity could not be directly demon-
strated in intact cells. Therefore, the question arose
whether it would be possible to directly register
trypsin activity in intact pancreatic acinar cells in
order to characterize trypsinogen activation in re-
sponse to hormonal hyperstimulation. Such an experi-
mental approach needs a membrane-permeant sub-
strate of high sensitivity and specificity.
w xLeytus et al. 9,10 introduced rhodamine deriva-
tives as fluorogenic substrates for serine proteases.
 .CBZ-Arg -Rhodamine 110, in particular, was de-2
scribed as a highly specific substrate for trypsin
w xcompared to other trypsin-like enzymes 10 . The
method is based on the drastic increase in fluores-
 .cence intensity 3500 fold resulting from the en-
zymic cleavage of one of the amide bonds in the
non-fluorescent bis-amide substrate. Furthermore, this
substrate exhibits a 50–300 fold increase in sensitiv-
ity of the protease activity measurements in compari-
son to the 7-amino-4-methylcoumarin-based ana-
logue. Recently, Rhodamine-based fluorogenic sub-
strates were used to analyse intracellular activities of
w xlysosomal proteases 11 .
In the present study, trypsinogen activation should
be directly followed in intact cells registering the
proteolytic activity in response to supraphysiological
 .concentrations of caeruelin. Applying CBZ-Arg -2
Rho 110 as a substrate and the benzamidine deriva-
 .tive Na- 2-naphthylsulfonyl -3-amidinopheny-
lalanine-carboxymethylpiperazide as potent inhibitor
w xof trypsin 12 , the occurrence of active trypsin within
acinar cells was investigated. The formation of TAP
was measured as an independent parameter to charac-
terize the caerulein-induced trypsinogen activation.
2. Materials and methods
2.1. Biochemicals
Purified collagenase was obtained from Worthing-
 .ton Biochemical Freehold, USA . Caerulein was a
 .product of Pharmacia Nuremberg, Germany . The
Rho 110-based protease substrates were purchased
 .from Molecular Probes Eugene, USA . Soybean
 .trypsin inhibitor I-S, 2S,3S -trans-epoxysuccinyl-L-
 .leucylamido-3-methylbutane ethyl ester E64d , and
 .the enzymes trypsin bovine pancreas , kallikrein
 .  .porcine pancreas , cathepsin B bovine spleen , chy-
 . motrypsin bovine pancreas and elastase porcine
. pancreas were products of Sigma Deisenhofen, Ger-
. many . The cathepsin B inhibitor N- L-3-trans-pro-
.pylcarbamoyloxirane-2-carbonyl -isoleucyl-proline
 . CA-074 was obtained from Bachem Heidelberg,
.Germany . The benzamidine derivative Na-
 .2-naphthylsulfonyl -3-amidinophenylalanine-car
boxymethylpiperazide was kindly provided by Dr P.
 .Wikstrom Pentapharm; Basel, Switzerland . The¨
TAP enzyme immunoassay kit was purchased from
 .Biotrin International Sinsheim-Reihen, Germany .
The a-amylase-EPS-kit was a product of Boehringer
 .Mannheim, Germany . All other chemicals were of
analytical grades.
2.2. Preparation and incubation of acini
 .Female Wistar rats HsdCpb:WU; 150–180 g were
purchased from Harlan-Winkelmann Borchen, Ger-
.many . Acinar cells were prepared from animals
fasted overnight according to Amsterdam and
w xJamieson 13 with some modifications proposed by
w xWilliams et al. 14 . The preparation was performed
with purified collagenase and without any additional
proteolytic enzyme or protease inhibitor. Acinar cells
 6approx. 3=10 rml in the fluorometric assay; ap-
6 .prox. 15=10 rml in the TAP assay were incubated
at 378C in a medium consisting of 140 mM NaCl,
2.8 mM KCl, 1.3 mM CaCl , 0.6 mM MgCl , 0.8 mM2 2
Na HPO , 10 mM glucose, 2 mM glutamine, essen-2 4
tial amino acids, and 10 mM N-2-hydroxyethyl-
X  .piperazine-N -2-ethanesulfonic acid HEPES , pH 7.4
and gassed with pure oxygen.
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2.3. Fluorometric assay of proteases
Acinar cells were preincubated with various con-
centrations of caerulein, then the Rho-110-based sub-
strate was added and finally the solution was trans-
ferred into the fluorometer cuvette. The measure-
ments with intact cells were performed throughout
w xwith 4 mM Rho 110-based substrate 11 . At this
concentration, the acinar cells were not damaged
within the experimental period as checked by both
trypan blue and propidium iodide exclusion. Further-
more, it was checked that this substrate concentration
was sufficient to be cleaved to a maximum of 5%
within the assay period. Under these conditions, the
increase in fluorescence solely results from the gener-
w xation of mono-amide-Rho 110 9 . This ensures a
proportional fluorescence increase with time and en-
zyme amount. To register trypsin activity, CBZ-
. w xArg -Rho 110 10 was used. To test the efficiency2
of the BA derivative as inhibitor of pancreatic pro-
teases, pancreatic elastase was measured with CBZ-
. Ala -Rho 110, pancreatic kallikrein with Pro-Phe-4 2
. Arg -Rho 110 and cathepsin B with CBZ-Ala-Arg-2
.Arg -Rho 110. Elastase and kallikrein activities were2
determined at pH 7.4 using the incubation medium
mentioned above. Cathepsin B was measured at pH
 .6.0 in a 2- N-morpholino ethanesulfonic acid
 .MES -buffered incubation medium. The cathepsin B
assay was performed in the presence of 2 mM L-cy-
steine. The Rho 110-fluorescence was registered
 .  .measuring at 485 nm excitation r525 nm emission
using a Perkin-Elmer LS50 B fluorometer.
2.4. Assays of amylase and TAP
Amylase release from acinar cells was determined
after incubation of the cells for 60 min in the pres-
ence of various concentrations of caerulein. To calcu-
late amylase secretion as percentage of total content,
the enzyme was measured in the supernatant after
centrifugation of intact cells for 1 min at 12,000=g
as well as in the supernatants of the resulting pellets
which were resuspended, sonified and centrifuged
under the same conditions.
For the determination of TAP, acinar cells were
incubated as described for the preincubation proce-
dure of the protease assay. At the end of the incuba-
tion, samples were supplemented with 5 mM EDTA
 .and 0.1% wtrvol Triton X100 and boiled for 10 min
w x7 . After centrifugation, the samples were stored at
y808C. To enhance the TAP concentrations of the
samples, they were dried by vacuum-rotation and
redissolved in one half of the original volume. The
assay was performed using a TAP enzyme im-
munoassay kit.
2.5. Statistical analysis of data
 .Data are given as mean values " S.E. for at
least four separate experiments. Statistical signifi-
cance analysis was carried out by means of Student’s
t-test for independent samples using SPSS for Win-
dows. At a level of p-0.05, differences were con-
sidered as significant.
3. Results
( )3.1. Induction of a CBZ-Arg -Rho 110-clea˝ing2
acti˝ity by caerulein
Pancreatic acinar cells cleaved the fluorogenic pro-
 .tease substrate CBZ-Arg -Rho 110 leading to an2
increase in fluorescence. In Fig. 1, traces of the
fluorescence measurement are demonstrated repre-
Fig. 1. Traces of fluorometric measurement demonstrating CBZ-
.Arg -Rho 110 cleavage by acinar cells after caerulein treatment.2
 6 .Acinar cells 3=10 rml were preincubated without and with
0.1 or 10 nM caerulein for 1 h, supplemented for 4 mM CBZ-
.Arg -Rho 110 and transferred into a stirred fluorometer2
 .cuvette.The fluorescence 485r525nm was registered for 30 min
and the serine protease inhibitor BA was added into the run of
supramaximally stimulated cells.
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senting acinar cells which were pretreated with
 .physiological 0.1 nM and supraphysiological
 .10 nM concentrations of caerulein. After addition of
the substrate, a 10–15 min lag phase can be observed
obviously indicating the substrate penetration into the
cells. In the following period, a progressive increase
in fluorescence occured. This may be due to the
continuous formation of the proteolytic activity after
the hormonal stimulus. The supraphysiological con-
centration of caerulein caused a remarkable enhance-
ment of the substrate cleavage, whereas low sub-
strate-cleaving activities were observed with unstimu-
lated and physiologically stimulated cells. The sensi-
tivity towards low concentrations of the BA inhibitor
indicates that a serine protease activity is responsible
for the major part of the substrate-splitting activity of
acinar cells. To investigate the dependence of the
formation of the substrate-cleaving activity on the
caerulein concentration, the induction of the prote-
olytic activity was determined for the concentration
 .range of 1 pM–0.1 mM caerulein Fig. 2 . The cellu-
lar response to the hormone was also determined for
the amylase secretion. Amylase secretion showed the
 .Fig. 2. Amylase secretion and CBZ-Arg -Rho 110 cleavage of2
acinar cells in response to caerulein treatment. Acinar cells
 6 .3=10 cellsrml were incubated for 1 h with the indicated
 .caerulein concentrations C, refers to unstimulated control . For
 .measuring amylase secretion % , aliquots were taken at 0, 30
and 60min and then further treated as described in Section 2. At
the last time-point samples were taken to register the proteolytic
 .activity I as described in Fig. 1. Results are given as means "
S.E. obtained from 4 experiments.
Table 1
 .Relative cleavage of CBZ-Arg -Rho 110 by proteases2
Enzyme pH Activity Relative
y1D F =min activity
y1.=nmol enzyme
Trypsin 7.4 24,900 100
Kallikrein 7.4 6.1 0.024
Cathepsin B 6.0 28.9 0.116
 .Elastase 7.4 0 -0.005
 .Chymotrypsin 7.4 0 -0.005
 .The protease activities were measured with 4 mM CBZ-Arg -2
Rho 110 at 378C.
The assays at pH 7.4 were performed in HEPES-buffered incuba-
tion medium.
The incubation buffer at pH 6.0 contained 20mM MES and
2 mM cysteine.
No measurable activity was found with elastase or chymotrypsin.
typical biphasic response with an inhibition at
caerulein concentrations )1 nM. It was only in the
range of high-dose inhibition that a significant in-
crease of the protease activity vs. the basal level
occurred. It was found in additional experiments that
 .the CBZ-Arg -Rho 110-cleaving activity was en-2
 .hanced to 120.3"9.1% ns7 at 0.1 nM and to
 .192.4"16.3% ns10 at 10 nM caerulein, respec-
tively, after 1 h of caerulein treatment.
( )3.2. Characterization of the CBZ-Arg -Rho2
110-clea˝ing acti˝ity
 .Although CBZ-Arg -Rho 110 was recommended2
w xas a trypsin substrate 10 , to what extent this sub-
strate could be cleaved by other pancreatic proteases
had to be evaluated. To this end, we measured the
activities of various purified enzymes with this sub-
 .strate Table 1 . This selection was focused on pan-
creatic enzymes which can affect this cleavage site
 .trypsin, kallikrein, cathepsin B and serine proteases
which occur in their active forms in the acutely
 .inflamed pancreas chymotrypsin, elastase . Although
these activities were compared on a molar and not on
an active site basis, the data show that trypsin activity
is preferentially registered with this substrate.
 .In addition to the specificity of CBZ-Arg -Rho2
110 as substrate for trypsin, it was checked that the
BA inhibitor acts sensitively towards trypsin com-
pared to other proteases of the pancreas. Titration
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Fig. 3. Inhibition of proteases by benzamidine. The protease
activities were measured with 4 mM Rho 110-based protease
 .substrate at 378C. Trypsin was measured with CBZ-Arg -Rho2
 .  .  .110 O , elastase with CBZ-Ala -Rho 110 ’ , kallikrein with4 2
 .  . Pro-Phe-Arg -Rho 110 I and cathepsin B with CBZ-Ala-2
.  .Arg- Arg -Rho 110 l . The assays at pH 7.4 were performed2
in HEPES- buffered incubation medium with the exception of
cathepsin B which was measured in medium at pH 6.0 containing
20 mM MES and 2 mM cysteine. The curves show representative
titrations out of 3 identical measurements for each enzyme.
curves for trypsin in comparison to pancreatic elas-
tase, tissue kallikrein and cathepsin B are shown in
Fig. 3 using the peptide-Rho 110 substrates designed
specifically. The enzymes were found to be about
100–500 times less sensitive towards BA than trypsin.
The substrate and inhibitor specificity observed makes
 .it very likely that the BA-sensitive CBZ-Arg -Rho2
110-cleaving activity is trypsin.
In order to further specify the enzymatic activity
which is observed after caerulein hyperstimulation,
the 21 kDa, cell-membrane non-permeant SBTI and
the cell-membrane permeant cysteine proteinase in-
hibitor E64d were tested in addition to BA. It is
 .shown in Fig. 4 that the CBZ-Arg -Rho 110-cleav-2
ing activity was sensitive to BA in the micromolar
range, whereas SBTI or E64d did not inhibit. It was
checked in separate enzymatic assays with purified
 .enzymes Section 2 that 2 mM SBTI completely
inhibited trypsin, and 10 mM E64d inhibited cathep-
sin B to more than 85%. The insensitivity of the
 .CBZ-Arg -Rho 110-cleaving activity towards E64d2
suggests that a cysteine proteinase does not con-
tribute to the substrate cleavage. The lack of effect of
SBTI indicates that the substrate cleavage occurred
intracellularly.
These data and the sensitivity of the caerulein-in-
 .duced CBZ-Arg -Rho 110-cleaving activity to the2
BA inhibitor lead to the conclusion that the registered
activity is trypsin due to trypsinogen activation.
3.3. Influence of inhibitors on the formation of acti˝e
trypsin
In the previous experiments the inhibitors were
added after the induction of protease activity by
caerulein. In order to obtain information about the
factors which are involved in the formation process
of trypsin activity, the influence of serine protease as
well as of cysteine proteinase inhibitors was tested.
To this end, the isolated acinar cells were preincu-
bated with BA or the cathepsin B inhibitor CA-074,
and then the cells were stimulated by supramaximal
concentrations of caerulein. In separate experiments
titrating the cathepsin B activity with this inhibitor
the concentration which totally blocks the enzyme
was found to be 0.1 mM. Therefore 10 mM CA-074
can be expected to be sufficient to totally inhibit the
 .Fig. 4. Effect of inhibitors on the CBZ-Arg -Rho 110 cleaving2
activity of supramaximally caerulein-stimulated acinar cells. Aci-
 6 .nar cells 3=10 rml were preincubated with 10nM caerulein
for 1 h and further treated as described in Fig. 1. Results are
given as means " S.E. obtained from 5 experiments. The
activity of the uninhibited caerulein-stimulated cells corre-
sponded to 1.52"0.19 D F =miny1=106 cells-1. Inhibitions by
 .BA were significant vs. the uninhibited cells P -0.01 at all
concentrations.
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cathepsin B activity also in the intact acinar cell. As
shown in Fig. 5, the proteolytic activity was strongly
suppressed in the presence of BA. In the presence of
CA-074, the trypsin activity was comparable to the
non-inhibited control. Identical results were found
 .with 0.1 mM CA-074 or E64d not shown . These
 .results suggest that the activation of the CBZ-Arg -2
Rho 110-cleaving enzyme may be independent of the
activity of cathepsin B. A possible role of a serine
protease or of trypsin itself in this process cannot be
detected by measuring enzymatic activity in the pres-
ence of BA. The parallel determination of TAP,
however, enables the investigation of the trypsinogen
to trypsin conversion by a method independent of
measuring the enzymatic activity. In Table 2, data are
 .given for the parallel estimation of CBZ-Arg -Rho2
110-cleaving activity and TAP formation in response
to 10 nM caerulein. Caerulein hyperstimulation in-
 .creased the CBZ-Arg -Rho 110-cleaving activity as2
well as the TAP concentration. This finding addition-
 .ally verifies that the CBZ-Arg -Rho 110-cleaving2
activity is trypsin. In the presence of BA the prote-
Fig. 5. Fluorometric traces demonstrating the effect of protease
 .inhibitors on the generation of the CBZ-Arg -Rho 110-cleaving2
activity in supramaximally stimulated acinar cells. Acinar cells
 6 .12–15=10 rml were preincubated in the presence of in-
 .hibitors 10 mM for 15 min. Then 10 nM caerulein was added
and the cells were further incubated for 1 h. An aliquot of this
sample representing 3=106 cellsrml was transferred into the
 .fluorometer cuvette containing 4 mM CBZ-Arg -Rho 110 in the2
preincubation medium. The incubation of the remaining portion
of the specimens was continued for 1 h, and then these samples
were treated as described for the TAP assay.
Table 2
Effect of serine protease and cathepsin B inhibition on the
generation of protease activity and TAP in caerulein-hyperstimu-
lated acinar cells
Preincubation Protease activity TAP
 .  .Inhibitor 10 mM Caerulein % of unstimulated cells
 .10 nM
y y 100 100
a ay q 316"17 185"13
b bBA q 45"3 122"11
CA-074 q 344"19 226"51
The measurement were performed as described in Fig. 5. Results
are means " S.E. obtained from at least 4 independent experi-
ments. Data for the protease activity and for TAP of the unstimu-
lated, uninhibited cells were 0.90"0.16 D F =miny1=106
cellsy1 and 0.163"0.010 pmol TAP=106 cellsy1, resp.
a p-0.05 vs. unstimulated cells.
b p-0.05 vs. caerulein-stimulated cells.
olytic activity was strongly suppressed to a level of
about 50% of the activity of unstimulated cells indi-
cating that BA also effectively blocks the trypsin
activity which is originally present in the acinar cells.
The TAP level was signifcantly reduced in the pres-
ence of BA as compared to the non-inhibited sam-
ples. Cathepsin B inhibition reduced neither the
 .CBZ-Arg -Rho 110-cleaving activity nor the TAP2
formation.
4. Discussion
Caerulein as CCK-analogue is known to stimulate
acinar zymogen secretion. At supraphysiological
doses of the hormone, the apical exocytosis ceases
w x4,5 . The impaired stimulus-secretion coupling dis-
turbs the regular metabolism leading to subcellular
w xredistribution of lysosomal hydrolases 15 , acinar
w xcell vacuolation 7 , and basolateral zymogen release
w x4 very early in the time course of caerulein pancre-
atitis. These observations favour the concept of an
intracellular origin of autodigestive processes in the
acutely inflamed pancreas, at least under experimen-
w xtal conditions 2 . Recent publications described an
early occurrence of proteolytic enzymes, especially of
trypsin, after starting the caerulein treatment of rats
w x3,7 . However, the mechanisms by which premature
proenzyme activation are initiated can hardly be in-
vestigated by biochemical assays on the tissue level.
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Therefore, isolated pancreatic cells or acini may be
a useful tool to investigate the intracellular events in
response to high concentrations of CCK or caerulein.
Indeed, isolated acini show a decrease in amylase
secretion at CCK concentrations exceeding those
w xcausing a maximum response 16 . This was also
found for the stimulation of isolated acinar cells with
 . w xcaerulein in the present work Fig. 2 . Leach et al. 8
demonstrated the occurrence of an active serine pro-
tease in CCK-hyperstimulated rat pancreatic acini via
its activating effect on other proteolytic zymogens.
Although these authors hypothesized that trypsinogen
activation is the underlying phenomenon, a direct
demonstration of trypsin activity in intact cells has
still not been described.
Rhodamine 110-based fluorogenic protease sub-
strates were successfully applied to analyse prote-
w xolytic activities within intact cells 11 . In the present
investigation, a bis-arginine-substituted derivative was
tested to register trypsin activity in isolated intact
acinar cells. Incubation of acinar cells with this sub-
strate resulted in enhanced fluorescence indicating a
substrate cleavage. Although the lack of effect of the
high-molecular weight SBTI indicates an intracellular
generation of the fluorochrome, the fluorescence
quantum yield of the fluorogenic product may depend
on its distribution between different cell compart-
ments as well as between the cell and the surrounding
medium. For this reason, a direct quantification of the
cleaving activity using an external protease standard
was not performed for the data of the present work.
Nevertheless, it is possible to quantify the cleaving
activity relatively as fluorescence increase over time
and, therefore, to compare these rates in different
metabolic states of the acinar cells.
Chromogenic or fluorogenic peptide substrates are
commonly applied in protease assays. Their cleavage
sites, although designed for a special enzyme, are of
limited specificity, however. This is also true for the
basic amino acid residues bound to fluorogenic
molecules in potential substrates for trypsin. How-
 .ever, CBZ-Arg -Rho 110 was cleaved preferentially2
by trypsin in comparison to other pancreatic enzymes
 .Table 1 . The additional introduction of the BA
 .inhibitor enabled us to identify the CBZ-Arg -Rho2
110-cleaving activity in acinar cells as trypsin. It
should be noticed that the applied BA inhibitor was
originally developed as an inhibitor of various serine
w xproteases of the blood clotting system 12 . However,
such enzymes should not occur in preparations of
acinar cells. The caerulein-induced increase in trypsin
activity was insensitive to the action of SBTI. This
indicates that the formation of active trypsin as well
as the substrate cleavage occur intracellularly.
 .The assumption that the CBZ-Arg -Rho 110-2
cleaving activity must be mainly attributed to trypsin
was confirmed by a parallel appearance of TAP in
response to supramaximal concentrations of caerulein
 .Table 2 . On the other hand, the formation of TAP
indicates a proteolytic activation of trypsinogen and
excludes a substrate cleavage by conformationally
changed trypsinogen without proteolytic activation
which might be theoretically possible. Using the ex-
perimental approach to register trypsin activtiy and to
measure trypsinogen activation via the formation of
TAP, the conditions for the intracellular trypsinogen
activation became accessible for further analysis. Flu-
orescence measurements showed that a trypsinogen
activation also proceeded in the unstimulated state
within the experimental period. This means that traces
of active trypsin may be physiologically present in
the pancreatic cell. Although the data of isolated cells
must not be transferred to the situation in the native
gland, other studies showed a measurable trypsin
w xactivity in pancreas homogenates 3 .
The mechanisms by which premature trypsinogen
w xactivation is initiated are not identified 17 . The
redistribution of lysosomal hydrolases in the course
of caerulein pancreatitis led to the hypothesis that
cathepsin B, which is able to activate trypsinogen in
w xvitro 18 , is responsible for trypsinogen activation
w x2 . Other concepts favour a trypsinogen auto-activa-
w xtion 19 which was also discussed as the underlying
mechanism of zymogen activation in CCK-hyper-
w xstimulated isolated acini 8 .
The data of the present study do not support the
concept of a cathepsin B-linked trypsinogen activa-
tion because CA-074, which was designed as a spe-
w xcific inhibitor of cathepsin B 20 , did not reduce the
 .formation of the CBZ-Arg -Rho 110-cleaving activ-2
ity or the formation of TAP if used in a concentration
100 times higher than necessary to totally inhibit the
 .enzyme Table 2 . However, an action by other cys-
teine proteases cannot be excluded. On the other
hand, BA inhibited the trypsin activity and the TAP
formation if added to the preincubation. Rather taking
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into account the specificity of BA as trypsin inhibitor,
our results give evidence of a mechanism of serine
protease-linked trypsinogen activation than of a
cathepsin B-dependent one. These results confirm
w xthose of Leach et al. 8 who found that the conver-
sion of procarboxypeptidase A1 was sensitive to-
wards BA inhibition. We found that caerulein hyper-
stimulation increased the cellular levels of active
trypsin and TAP. This excludes a considerable neu-
tralization of the generated trypsin activity by en-
dogenous pancreatic inhibitors, e.g. the pancreatic
secretory trypsin inhibitor PSTI. In this case, the
extent of TAP formation should remarkably exceed
the measurable proteolytic activity. Although it is
imaginable that the pancreatic inhibitors are less effi-
cient in inhibiting the cleavage of low-molecular
peptide-substrates, this is not very likely because the
 .21 kD SBTI effectively inhibited the CBZ-Arg -Rho2
 .110-cleavage by trypsin in vitro not shown . The
results of the present work and those of Leach et al.
w x8 demonstrating a proenzyme conversion favour the
hypothesis that trypsinogen activation in hormonal-
hyperstimulated acinar cells requires an endoprote-
olytic action of a serine protease, very likely of
trypsin.
5. Note added in proof
After submission of the present paper, Saluja et al.
 .Gastroenterology 113, 304–310 published data
showing an inhibition by 1 mM E64d of trypsinogen
activation in isolated acini hyperstimulated by
caerulein. Testing 1 mM CA-074 in experiments as
given in Fig. 5, we found no inhibition of the benza-
 .midine-sensitive CBZ-Arg R 110-cleaving activ-2
ity.
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